Skip to main content
Caplight Logo









Rampart IC

Rampart IC

Private
Birmingham, AlabamaHealthcare & Life Scienceshttps://rampart.com/

Last Round

Series B

Apr 24, 2025

Total Funding Raised

$24.7M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Rampart IC is a medical technology company that develops and provides radiation safety and orthopedic protection solutions for interventional suites.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

radiation shieldingradiation protectionapron-free shieldinglead-free protectioninterventional radiologyinterventional cardiologymedical devicecath lab equipmentEP lab equipmentmedtechoccupational healthdosimetrycapital equipmentradiation measurementgovernment contracts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rampart IC Comparables

Compare Rampart IC with similar companies based on industry and business-model similarity.

Rampart IC comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Radiaction Medical
88%
Egg Medical, Inc.
88%
TIDI Products
79%

Rampart IC Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 24, 2025
SeedSep 16, 2020

Key People

Founding team and executive leadership

Bob Foster

Founder, Chief Medical Officer

Founding Team

Ashley Lee

CFO

Executive Team

Rob Williamson

Chief Revenue Officer (CRO), Member Board of Directors

Executive Team

Rampart IC Investors

Notable investors and investment history

Rampart IC investors
InvestorRounds
Vensana CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Grew 19% QoQ, from 68 to 81 employees.

  • Jul 26, 2026

    Monthly visitors grew 54% MoM, reaching 1.5K.

Recent news

Latest coverage and updates

  • files_suit_againstAug 11, 2026

    Rampart filed suit against Egg Medical, Inc. on Aug 11th '26.

Rampart IC Filings

Explore SEC and related filing metadata, where available.

Rampart IC filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Rampart IC's valuation, stock price, and market status.

Is Rampart IC a public or private company?

Rampart IC is a private company.

What is the current stock price of Rampart IC?

Rampart IC is a private company with no public stock price. No recent secondary market data is available.

How much is Rampart IC worth (valuation)?

Valuation information for Rampart IC is not publicly available.

Can I buy Rampart IC stock?

Rampart IC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Rampart IC's last funding round?

Rampart IC's most recent funding round was Series B on April 24, 2025.

Who are the main investors in Rampart IC?

Key investors in Rampart IC include Vensana Capital.

Will Rampart IC IPO soon?

No public IPO plans have been announced for Rampart IC.

How can I track Rampart IC secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rampart IC's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBirmingham, Alabama
Employee Range57
Year Founded2014
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?